Elsevier announces new journal on inflammatory bowel diseases

The first issue of the Journal of Crohn’s and Colitis is available in September

Amsterdam, 06 September 2007 – Elsevier in partnership with the European Crohn’s and Colitis Organisation (ECCO) are set to launch the Journal of Crohn’s and Colitis, a new international journal on inflammatory bowel diseases (IBD). This quarterly journal will be the official journal of the ECCO society and the first print issue will be available in September 2007.

The Journal of Crohn's and Colitis is concerned with the dissemination of knowledge on clinical, basic science and innovative methods related to inflammatory bowel diseases. The journal will publish original articles, review papers, editorials, leading articles, view points, case reports, innovative methods and letters to the editor. Supplemental issues of the journal will be published under a separate title, Journal of Crohn's and Colitis Supplements.

Miquel Gassull, M.D., Ph.D., Hospital Universitari Germans Trias I Pujol in Badalona, Spain and president of ECCO, will serve as the Editor-in-Chief of the new journal. The Editor-in-Chief is joined by a group of prestigious associate editors including Yehuda Chowers, Jean-Frédéric Colombel, Daan Hommes, Jack Satsangi, Stefan Schreiber, Séverine Vermeire and the consensus and guidelines editors Eduard Stange and Simon Travis.

“Although it is the official journal of ECCO, the Journal of Crohn’s and Colitis is open to everyone in the world interested and working in the field of inflammatory bowel diseases” commented Miquel Gassull. “This will become a high quality journal, opening an interactive pathway between clinicians and basic scientists, publishing the best reviews, clinical trials, good observational data, modern epidemiology and relevant breaking news on the diagnosis and therapy of IBD.”

Members of ECCO will receive a subscription to the Journal of Crohn’s and Colitis as a benefit of their membership. Members and individual subscribers will be able to access the entire contents of each issue on the journal’s website (http://ww.ecco-jccjournal.org/). The journal will also be accessible through Elsevier’s online database ScienceDirect (http://www.sciencedirect.com/), the world’s largest electronic collection of science, technology and medicine full-text and bibliographic information.

# # #

About ECCO
The European Crohn’s and Colitis Organisation (ECCO) was founded in 2001 as the European association of national inflammatory bowel diseases (IBD) study groups. The mission of ECCO is to strive for optimised care for patients with IBD in all aspects. To this end, ECCO will adopt and further all efforts that lead to an improvement in the use of current therapies and procedures, develop guidelines with the highest possible process and content quality, and define better and more valid outcome parameters for the therapy of IBD. In addition, ECCO promotes the specialist, postgraduate education in IBD and scientific projects in IBD.

About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com